The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


LYXUMIA

20 Microgram Solution for injection in pre-filled pen

Sanofi-Aventis GroupeEU/1/12/811/002-005

Main Information

Trade NameLYXUMIA
Active SubstancesLIXISENATIDE
Strength20 Microgram
Dosage FormSolution for injection in pre-filled pen
Licence HolderSanofi-Aventis Groupe
Licence NumberEU/1/12/811/002-005

Group Information

ATC CodeA10BX10 lixisenatide

Status

Authorised/WithdrawnAuthorised
Licence Issued01/02/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back